Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. CLRB has been the subject of a number of other research reports. Oppenheimer reaffirmed a “market perform” rating on shares of Cellectar […]
Stock analysts at StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. CLRB has been the subject of a number of other research reports. Oppenheimer reaffirmed a “market perform” rating on shares of Cellectar […]
